TY  - GEN
AU  - Pasqualetti,Francesco
AU  - Pace,Andrea
AU  - Gonnelli,Alessandra
AU  - Villani,Veronica
AU  - Cantarella,Martina
AU  - Delishaj,Durim
AU  - Vivaldi,Caterina
AU  - Molinari,Alessandro
AU  - Montrone,Sabrina
AU  - Pellerino,Alessia
AU  - Franchino,Federica
AU  - Baldaccini,Davide
AU  - Lombardi,Giuseppe
AU  - Lolli,Ivan
AU  - Catania,Francesca
AU  - Bazzoli,Elena
AU  - Morganti,Riccardo
AU  - Fabi,Alessandra
AU  - Zagonel,Vittorina
AU  - Bocci,Guido
AU  - Fabrini,Maria Grazia
AU  - Rudà,Roberta
AU  - Soffietti,Riccardo
AU  - Paiar,Fabiola
TI  - Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology
SN  - 1537-453X
PY  - 2019///0705
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Antineoplastic Agents, Immunological
KW  - therapeutic use
KW  - Bevacizumab
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Female
KW  - Follow-Up Studies
KW  - Glioblastoma
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Nitrosourea Compounds
KW  - Organophosphorus Compounds
KW  - Prognosis
KW  - Retrospective Studies
KW  - Salvage Therapy
KW  - Survival Rate
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1097/COC.0000000000000464
ER  -